MedTrace Logo

Second Line Treatment of Knee Osteochondral Lesion With Treated Osteochondral Graft

NCT02430558 · Status: TERMINATED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2022-09-27

No results posted yet for this study

Summary

Patient with IKDC score \< 65, pretreated with mosaicplasty or ACI ( with matrix or not) within \> 18 months, with one or two osteochondral lesions are recruited to have treated osteochondral allografts in mosaicplasty.

Conditions

  • Cartilage Injury

Interventions

BIOLOGICAL

OD-PHOENIX

Decellularized, freeze-dried, irradiated osteochondral allograft

Sponsors & Collaborators

  • TBF Genie Tissulaire

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-05
Primary Completion
2021-06-15
Completion
2021-06-15

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02430558 on ClinicalTrials.gov